Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 101–200 of 1,000
Gronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., & Laniado Schwartzman, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410638200 · Cited by 310
Self-citationResolution of inflammation is altered in Alzheimer's disease
Wang, X., Zhu, M., Hjorth, E., Cortés‐Toro, V., Eyjolfsdottir, H., Graff, C., Nennesmo, I., Palmblad, J., Eriksdotter, M., Sambamurti, K., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.024 · Cited by 301
“It is well known that these enzymes produce inflammatory FAs [46], and production of SPMs by these enzymes is dependent on so-called “class-switching” for SPMs to be produced [47].”
Self-citationPhagocytosis of Apoptotic Cells in Resolution of Inflammation
Kourtzelis, I., Hajishengallis, G., & Chavakis, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00553 · Cited by 300
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
“During this time frame, there is an induction of 15-LOX expression that contributes to the formation of select SPM (28) (Figure 3).”
BackgroundSelf-citationThe role of neutrophils in inflammation resolution
Jones, H. R., Robb, C. T., Perretti, M., & Rossi, A. G. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.007 · Cited by 297
Canny, G., Levy, O., Furuta, G. T., Narravula-Alipati, S., Sisson, R. B., Serhan, C. N., & Colgan, S. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052533799 · Cited by 295
Self-citationResolvins and protectins: mediating solutions to inflammation
Kohli, P., & Levy, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00290.x · Cited by 292
“In addition, PD1 decreases levels of PGD2, a key prostanoid implicated in airway responses as well as the induction of 15-LOX, and consequently, LX biosynthesis (Levy et al., 2001; 2007a).”
BackgroundSelf-citationOh, S. F., Pillai, P. S., Recchiuti, A., Yang, R., & Serhan, C. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42545 · Cited by 290
Self-citationPathological mechanisms and therapeutic outlooks for arthrofibrosis
Usher, K. M., Zhu, S., Mavropalias, G., Carrino, J. A., Zhao, J., & Xu, J. (2019) · Bone Research · doi:10.1038/s41413-019-0047-x · Cited by 285
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
“LXA4 is present in exudative pleural effusions from human subjects with pleural disease and is associated with pleural exudates that are rich in neutrophils (Levy et al., 2001).”
BackgroundInfluentialSelf-citationAnnexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles
Dalli, J., Norling, L. V., Renshaw, D., Cooper, D., Leung, K.-Y., & Perretti, M. (2008) · Blood · doi:10.1182/blood-2008-02-140533 · Cited by 277
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
N. Serhan, C., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 276
Self-citationCyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury
Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L. E., & Levy, B. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5033 · Cited by 275
“LXs are generated in respiratory tissues and block airway inflammation and hyperresponsiveness in an experimental model of asthma (17).”
BackgroundSelf-citationDobrev, D., Heijman, J., Hiram, R., Li, N., & Nattel, S. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00759-w · Cited by 268
BARNES, P. J. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.03721.x · Cited by 270
The role of non-resolving inflammation in atherosclerosis
Kasikara, C., Doran, A. C., Cai, B., & Tabas, I. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97950 · Cited by 266
Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., & Serhan, C. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405445101 · Cited by 266
Self-citationThe ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors?
Sitkovsky, M. V., & Ohta, A. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.004 · Cited by 265
Johnson, G. H., & Fritsche, K. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2012.03.029 · Cited by 268
Dynamic lipidome alterations associated with human health, disease and ageing
Hornburg, D., Wu, S., Moqri, M., Zhou, X., Contrepois, K., Bararpour, N., Traber, G. M., Su, B., Metwally, A. A., Avina, M., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00880-1 · Cited by 260
Key mechanisms governing resolution of lung inflammation
Robb, C. T., Regan, K. H., Dorward, D. A., & Rossi, A. G. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0560-6 · Cited by 261
“Presently, lipoxins are the most studied family of pro-resolution lipids and their levels considerably increase during the resolution phase of inflammation [5].”
BackgroundThe Management of Inflammation in Periodontal Disease
Van Dyke, T. E. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080173 · Cited by 261
Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.001 · Cited by 257
“(Right) Lipid mediator class switching is the process we introduced (Levy et al., 2001) to describe the temporal change in lipid mediators from initiation of inflammation to resolutionphase mediators as a biosynthetically active process, switching from PG and LT production to translational…”
BackgroundInfluentialSelf-citationRanneh, Y., Ali, F., Akim, A. M., Hamid, H. A., Khazaai, H., & Fadel, A. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0285-9 · Cited by 250
“Endogenously inflammatory mediators derived from lipid have a significant role in resolving inflammation [18].”
BackgroundDiminished Lipoxin Biosynthesis in Severe Asthma
Levy, B. D., Bonnans, C., Silverman, E. S., Palmer, L. J., Marigowda, G., & Israel, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1413oc · Cited by 250
“These compounds promote resolution of cytokine-driven acute inflammation (25) and reduce airway inflammation in experimental asthma (14).”
BackgroundSelf-citationRajakariar, R., Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., Fitzgerald, D., Yaqoob, M. M., & Gilroy, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707394104 · Cited by 253
Norling, L. V., Dalli, J., Flower, R. J., Serhan, C. N., & Perretti, M. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.249508 · Cited by 249
“responses and lipid mediator class switching that enhances the resolution of acute inflammation.(35) Because RvD1 also”
Self-citationMonocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration
Saclier, M., Cuvellier, S., Magnan, M., Mounier, R., & Chazaud, B. (2013) · The FEBS Journal · doi:10.1111/febs.12166 · Cited by 248
Ariel, A., Li, P.-L., Wang, W., Tang, W.-X., Fredman, G., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509796200 · Cited by 246
Self-citationAirway Lipoxin A 4 Generation and Lipoxin A 4 Receptor Expression Are Decreased in Severe Asthma
Planagumà, A., Kazani, S., Marigowda, G., Haworth, O., Mariani, T. J., Israel, E., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Calhoun, W. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-061oc · Cited by 247
Self-citationDas, U. N. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-37 · Cited by 245
Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
Dalli, J., Winkler, J. W., Colas, R. A., Arnardottir, H., Cheng, C.-Y. C., Chiang, N., Petasis, N. A., & Serhan, C. N. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.010 · Cited by 243
“1), has led to identification of previously unexplored biochemical pathways in inflammation and its resolution as well as in many other disease processes (Levy et al., 2001; Patti et al., 2012; Serhan et al., 2000).”
BackgroundSelf-citationAnti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
Chiang, N., Arita, M., & Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.003 · Cited by 239
“Also, both the temporal and spatial components in LX formation and actions are important determinants in their impact during an acute inflammatory reaction [52].”
BackgroundSelf-citationMaderna, P., & Godson, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00386.x · Cited by 236
“The new genus of pro-resolving mediators of molecules include lipoxins (LXs) and their aspirin-triggered carbon-15 epimers (ATL) (Levy et al., 2001; Serhan, 2005), as well as the recently discovered resolvins and protectins which are derived from w-3 fatty acids (Serhan et al., 2000; 2008a,b).”
BackgroundSchif‐Zuck, S., Gross, N., Assi, S., Rostoker, R., Serhan, C. N., & Ariel, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201040801 · Cited by 237
Self-citationGender differences in the n-3 fatty acid content of tissues
Childs, C. E., Romeu-Nadal, M., Burdge, G. C., & Calder, P. C. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108005983 · Cited by 238
Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
Perretti, M., Leroy, X., Bland, E. J., & Montero-Melendez, T. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.007 · Cited by 227
“These mediators, termed lipoxins, are downstream products of arachidonate metabolism, generated through a then novel transcellular mechanism, requiring a two-step biosynthetic pathway with enzymes brought into close vicinity by two distinct cell types [1,2].”
Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins
Serhan, C. N. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200503000-00003 · Cited by 227
Self-citationSansbury, B. E., & Spite, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.307308 · Cited by 226
“During the transition from inflammation to resolution, lipid mediator class switching takes place in which initial formation of proinflammatory mediators induce the production of enzymes that enable the reprogramming of leukocytes to generate specialized proresolving lipid mediators (SPMs) from the same PUFA precursor…”
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Viola, J. R., Lemnitzer, P., Jansen, Y., Csaba, G., Winter, C., Neideck, C., Silvestre-Roig, C., Dittmar, G., Döring, Y., Drechsler, M., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309492 · Cited by 226
“PGE2, as well as PGD2, on the other hand has been reported to have a dual, and paradoxical, role, functioning as proinflammatory and proresolving mediator, depending on its location.(38) In the context of atherosclerosis, PGE2 is associated with disease progression, mediated by the activation of platelets(33) and cons…”
BackgroundModifiable risk factors in periodontitis: at the intersection of aging and disease
Reynolds, M. A. (2014) · Periodontology 2000 · doi:10.1111/prd.12047 · Cited by 226
Ketamine and Peripheral Inflammation
De Kock, M., Loix, S., & Lavand'homme, P. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12104 · Cited by 224
Helminth Immunomodulation in Autoimmune Disease
Smallwood, T. B., Giacomin, P. R., Loukas, A., Mulvenna, J. P., Clark, R. J., & Miles, J. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00453 · Cited by 224
Long-chain fatty acids and inflammation
Calder, P. C. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000067 · Cited by 222
Loynes, C. A., Lee, J. A., Robertson, A. L., Steel, M. J., Ellett, F., Feng, Y., Levy, B. D., Whyte, M. K. B., & Renshaw, S. A. (2018) · Science Advances · doi:10.1126/sciadv.aar8320 · Cited by 222
Self-citationSuppression of allergic inflammation by the prostaglandin E receptor subtype EP3
Kunikata, T., Yamane, H., Segi, E., Matsuoka, T., Sugimoto, Y., Tanaka, S., Tanaka, H., Nagai, H., Ichikawa, A., & Narumiya, S. (2005) · Nature Immunology · doi:10.1038/ni1188 · Cited by 221
Infection and inflammatory mechanisms
Van Dyke, T. E., & van Winkelhoff, A. J. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340018 · Cited by 221
Pattern recognition receptor function in neutrophils
Thomas, C. J., & Schroder, K. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.008 · Cited by 214
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Kamaly, N., Fredman, G., Subramanian, M., Gadde, S., Pesic, A., Cheung, L., Fayad, Z. A., Langer, R., Tabas, I., & Cameron Farokhzad, O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303377110 · Cited by 214
“The most notable drugs that impair resolution are the COX-2 inhibitors that block the production of PGE2 and PGD2, two critical mediators that initiate resolution (41).”
BackgroundOral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage
Hasturk, H., Kantarci, A., & Van Dyke, T. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00118 · Cited by 212
“There is a high concentration of cells containing lipoxygenases, and corresponding pro-inflammatory products, a “class switch” may occur within neutrophils (Levy et al., 2001; Van Dyke, 2007).”
BackgroundHsiao, H.-M., Sapinoro, R. E., Thatcher, T. H., Croasdell, A., Levy, E. P., Fulton, R. A., Olsen, K. C., Pollock, S. J., Serhan, C. N., Phipps, R. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058258 · Cited by 209
“However, PGE2 also has anti-inflammatory properties in neutrophils, and is involved in activating lipid mediator class switching between pro-inflammatory and pro-resolving mediators [44,45].”
BackgroundSelf-citationLima-Garcia, J., Dutra, R., da Silva, K., Motta, E., Campos, M., & Calixto, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01345.x · Cited by 209
“Initially, Levy et al. (2001) have demonstrated a lipid mediator class switching during the spontaneous resolution of acute inflammatory response.”
BackgroundPolarized immune responses differentially regulate cancer development
Johansson, M., DeNardo, D. G., & Coussens, L. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00600.x · Cited by 209
“Following viral infection, for example, infected cells rapidly release type-I interferons (IFN-a and/or b) (22), that activate early viral defense programs, and are also”
BackgroundInflammation and resolution in obesity
Soták, M., Clark, M., Suur, B. E., & Börgeson, E. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01047-y · Cited by 198
Lipoxins and new lipid mediators in the resolution of inflammation
SCHWAB, J., & SERHAN, C. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.006 · Cited by 207
Self-citationCarcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 205
“Thus, inhibition of COX-2 impairs resolution of inflammation because prostaglandins such as PGE2 initiate a lipid mediator class switching to SPMs such as lipoxins to accelerate the resolution of inflammation (Levy et al., 2001).”
Self-citationSerhan, C. N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00047-3 · Cited by 205
Self-citationLeukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms
Gavins, F. N. E., Yona, S., Kamal, A. M., Flower, R. J., & Perretti, M. (2003) · Blood · doi:10.1182/blood-2002-11-3411 · Cited by 205
“Examples of the latter ones are the process of neutrophil apoptosis3 or the local-acting autocoids adenosine or lipoxin A4 (LXA4).(4,5) The glucocorticoid-regulated protein annexin 1 is one of these”
BackgroundBuchman, T. G. (2002) · Nature · doi:10.1038/nature01260 · Cited by 207
The Innate Immune Response to Mycobacterium tuberculosis Infection
Ravesloot-Chávez, M. M., Van Dis, E., & Stanley, S. A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-010426 · Cited by 201
Galvão, I., Sugimoto, M. A., Vago, J. P., Machado, M. G., & Sousa, L. P. (2018) · Immunopharmacology and Inflammation · doi:10.1007/978-3-319-77658-3_1 · Cited by 202
Nitro-fatty Acid Reaction with Glutathione and Cysteine
Baker, L. M. S., Baker, P. R. S., Golin-Bisello, F., Schopfer, F. J., Fink, M., Woodcock, S. R., Branchaud, B. P., Radi, R., & Freeman, B. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704085200 · Cited by 200
Kremmyda, L.-S., Vlachava, M., Noakes, P. S., Diaper, N. D., Miles, E. A., & Calder, P. C. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8186-2 · Cited by 198
“PGE2 inhibits 5-LOX activity, down-regulating LT production [19].”
Immunomodulation by Polyunsaturated Fatty Acids: Mechanisms and Effects
Stulnig, T. M. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000074898 · Cited by 198
“However, PGE 2 inhibits 5-LOX, thereby interfering with production of LTx 4 , and AA also gives rise to antiinflammatory lipoxins generated via 15-LOX [”
BackgroundOral infections and cardiovascular disease
Kholy, K. E., Genco, R. J., & Van Dyke, T. E. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.03.001 · Cited by 197
Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids
Ali, O., & Szabó, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115693 · Cited by 191
The resolution of inflammation: the devil in the flask and in the details
Serhan, C. N. (2011) · The FASEB Journal · doi:10.1096/fj.11-0502ufm · Cited by 196
“Notably, LXs clearly display unique actions and do not function like PGE2 in the inflammatory response and its resolution, in that LXs accelerate resolution, as when and where in their biosynthesis proved critical in identifying their functions, since they are produced locally in the resolution phase in exudates (29,…”
BackgroundSelf-citationOrtiz-Muñoz, G., Mallavia, B., Bins, A., Headley, M., Krummel, M. F., & Looney, M. R. (2014) · Blood · doi:10.1182/blood-2014-03-562876 · Cited by 193
Gan, H., Lee, J., Ren, F., Chen, M., Kornfeld, H., & Remold, H. G. (2008) · Nature Immunology · doi:10.1038/ni.1654 · Cited by 192
The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase
Vance, R. E., Hong, S., Gronert, K., Serhan, C. N., & Mekalanos, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307308101 · Cited by 192
Self-citationResolvin E2 Formation and Impact in Inflammation Resolution
Oh, S. F., Dona, M., Fredman, G., Krishnamoorthy, S., Irimia, D., & Serhan, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103652 · Cited by 189
“Novel cellular and molecular factors were identified to enhance resolution, which appear to be programmed responses at the tissue level in this process (8, 9) (recently reviewed in 10, 11).”
BackgroundSelf-citationMaderna, P., Yona, S., Perretti, M., & Godson, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3727 · Cited by 190
“In this regard, it is noteworthy that the biosynthesis of specific mediators that actively promote the resolution of inflammation has been demonstrated (10, 11, 32).”
BackgroundInfluentialHost modulation therapy with anti‐inflammatory agents
Preshaw, P. M. (2018) · Periodontology 2000 · doi:10.1111/prd.12148 · Cited by 188
Campbell, E. L., MacManus, C. F., Kominsky, D. J., Keely, S., Glover, L. E., Bowers, B. E., Scully, M., Bruyninckx, W. J., & Colgan, S. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914730107 · Cited by 186
White, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A. (2010) · Diabetes · doi:10.2337/db10-0054 · Cited by 185
“To test this, we subjected mice to a dorsal air-pouch TNF challenge, an established model of self-resolving inflammation (13).”
MethodLipoxins and aspirin-triggered lipoxins in resolution of inflammation
Romano, M., Cianci, E., Simiele, F., & Recchiuti, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.083 · Cited by 183
Park, G. Y., & Christman, J. W. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00513.2005 · Cited by 182
“It carries unique action to promote resolution of cytokine-driven acute inflammation (53).”
Chan, M. M.-Y., & Moore, A. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903816 · Cited by 183
“In vitro, with polymorphonuclear neutrophils extracted from air pouch and bronchial epithelial cells isolated from acid-injured lung, PGE2 is only transiently produced to provide a transitional signal for inducing LXA4 production and mediating evolution of inflammation to resolution (2, 46).”
BackgroundDevassy, J. G., Leng, S., Gabbs, M., Monirujjaman, M., & Aukema, H. M. (2016) · Advances in Nutrition · doi:10.3945/an.116.012187 · Cited by 183
“For example, resolvins, lipoxins, protectins, and maresins initiate pathways that signal the termination of an acute inflammatory phase (161).”
Eickmeier, O., Seki, H., Haworth, O., Hilberath, J. N., Gao, F., Uddin, M., Croze, R. H., Carlo, T., Pfeffer, M. A., & Levy, B. D. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.66 · Cited by 182
Self-citationMaresin 1 biosynthesis during platelet–neutrophil interactions is organ-protective
Abdulnour, R.-E. E., Dalli, J., Colby, J. K., Krishnamoorthy, N., Timmons, J. Y., Tan, S. H., Colas, R. A., Petasis, N. A., Serhan, C. N., & Levy, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407123111 · Cited by 181
“Early cellular and biochemical events in acute inflammation are pivotal to timely resolution (9, 10).”
BackgroundSelf-citationWang, C.-W., Colas, R. A., Dalli, J., Arnardottir, H. H., Nguyen, D., Hasturk, H., Chiang, N., Van Dyke, T. E., & Serhan, C. N. (2016) · Infection and Immunity · doi:10.1128/iai.01131-15 · Cited by 179
“During self-resolving inflammation, there is a temporal lipid mediator (LM) class switch from classic proinflammatory lipid mediators, such as leukotrienes (LT) and prostaglandins (PG), to SPMs that include lipoxins (LX), resolvins (Rv), protectins (PD), and maresins (MaR) (2, 3).”
Self-citationLipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“It is believed that these lipids mediators are generated in situ when neutrophils express 5-LOX at the onset of resolution as they begin to apoptose (107).”
BackgroundNovel ? ? 3-derived local mediators in anti-inflammation and resolution
NSERHAN, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.09.002 · Cited by 181
Miles, E. A., Childs, C. E., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13010247 · Cited by 177
“Although many of the actions of PGE2 are clearly pro-inflammatory and pro-allergic, it suppresses 5-LOX, inhibiting synthesis of LTs (which are generally pro-inflammatory: see below) and induces 15-LOX to promote the synthesis of pro-resolution lipoxins [33,34].”
BackgroundLong-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients
Calder, P. C. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000400004 · Cited by 178
“Braz J Med Biol Res 36(4) 2003 n-3 Fatty acids in critical illness”
BackgroundMechanisms of Resolution of Inflammation: A Focus on Cardiovascular Disease
Maskrey, B. H., Megson, I. L., Whitfield, P. D., & Rossi, A. G. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213850 · Cited by 177
“Lipid mediators derived from arachidonic acid (AA; 20:4, omega-6 [ -6]) are known to regulate the inflammatory process and generate pro-inflammatory, anti-inflammatory, and proresolving mediators (Figure 2).34–36 Indeed, synthesis of the cyclooxygenase (COX)–generated eicosanoid, prostaglandin E2, regulates blood flow…”
BackgroundNutritional Regulation of Porcine Bacterial-Induced Colitis by Conjugated Linoleic Acid
Hontecillas, R., Wannemeulher, M. J., Zimmerman, D. R., Hutto, D. L., Wilson, J. H., Ahn, D. U., & Bassaganya-Riera, J. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.7.2019 · Cited by 177
“, polymorphonuclear neutrophilic leukocyte chemotaxis and release of superoxide anions) (49).”
BackgroundVagus nerve controls resolution and pro-resolving mediators of inflammation
Mirakaj, V., Dalli, J., Granja, T., Rosenberger, P., & Serhan, C. N. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132103 · Cited by 176
“Accordingly, in the early inflammatory events we found that netrin1 lowered LTB4, a primary che moattractant, and temporally regulated both PGD2 and PGE2, which are key in mediator class switching in resolution (Levy et al., 2001).”
BackgroundSelf-citationBang, S., Yoo, S., Yang, T., Cho, H., Kim, Y., & Hwang, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00909.x · Cited by 176
“It may be relevant to note that there seems to be a switch of lipid mediators during inflammation, between w-6 fatty acid derivatives as pro-inflammatory mediators in the early stages and w-3 fatty acid derivatives as pro-resolvers in the later stages (Levy et al., 2001; Serhan and Chiang, 2008).”
BackgroundDevchand, P. R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R., Gronert, K., & Serhan, C. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0770com · Cited by 176
“nation and regulation of key signaling pathways (2).”
BackgroundResultSelf-citationSerhan, C. N. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0695-8 · Cited by 175
“We have learned that there is a temporal dissociation between eicosanoids, where PGs and leukotrienes antecede the biosynthetic assembly of the enzymes required for the production of LXs, and these studies open up the possibility that other pathways are operative within the terrain of resolution (Levy et al. 2001; Gil…”
BackgroundInfluentialSelf-citationA novel role for phospholipase A 2 isoforms in the checkpoint control of acute inflammation
Gilroy, D. W., Newson, J., Sawmynaden, P., Willoughby, D. A., & Croxtall, J. D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0837com · Cited by 174
“(5) and contributes to inflammatory cell clearance by”
BackgroundLipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
Svensson, C. I., Zattoni, M., & Serhan, C. N. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061826 · Cited by 175
Self-citationAriel, A., Chiang, N., Arita, M., Petasis, N. A., & Serhan, C. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6266 · Cited by 174
Self-citationHage, C., Michaëlsson, E., Linde, C., Donal, E., Daubert, J.-C., Gan, L.-M., & Lund, L. H. (2017) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.116.001633 · Cited by 174
“The IPA Core analysis compares a biomarker pattern with annotated findings, listing the likelihood of LVEDd (mm) 47 (43; 53) 49 (44; 53) 46 (43; 52) 0.”
MethodBoosting Inflammation Resolution in Atherosclerosis
Fredman, G., & Tabas, I. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 174
Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe?
Cooper, P. R., Palmer, L. J., & Chapple, I. L. C. (2013) · Periodontology 2000 · doi:10.1111/prd.12025 · Cited by 172
The Role of Neutrophils and Monocytes in Innate Immunity
Kantari, C., Pederzoli-Ribeil, M., & Witko-Sarsat, V. (2008) · Contributions to Microbiology · doi:10.1159/000136335 · Cited by 169
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.